Lenalidomide Plus CHOP in Angioimmunoblastic T-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Integrative Analysis of a Phase 2 Trial Combining Lenalidomide With CHOP in Angioimmunoblastic T-Cell Lymphoma
Blood Adv 2021 Jan 26;5(2)539-548, F Lemonnier, V Safar, A Beldi-Ferchiou, AS Cottereau, E Bachy, G Cartron, V Fataccioli, L Pelletier, C Robe, A Letourneau, E Missiaglia, S Fourati, MP Moles-Moreau, A Delmer, R Bouabdallah, L Voillat, S Becker, C Bossard, M Parrens, O Casasnovas, V Cacheux, C Régny, V Camus, MH Delfau-Larue, M Meignan, L de Leval, P Gaulard, C HaiounFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.